Aulos Bioscience
PrivateLast Round
Series A
Extension
Aug 1, 2023
Total Funding Raised
$60M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aulos Bioscience is a biotechnology company that develops innovative immuno-oncology therapeutics and IL-2 targeting antibodies to direct patients' immune systems toward killing solid tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aulos Bioscience Comparables
Compare Aulos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 85% | |
| Anaveon | 84% | |
| Anwita Biosciences Inc. | 80% |
Aulos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 1, 2023 | ||||
| Series A | Jan 8, 2021 |
Key People
Founding team and executive leadership
Aulos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 174% MoM, reaching 6K.
- Nov 12, 2025
Developing a human monoclonal antibody targeting regulatory T cells.
Aulos Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aulos Bioscience's valuation, stock price, and market status.
Is Aulos Bioscience a public or private company?
Aulos Bioscience is a private company.
What is the current stock price of Aulos Bioscience?
Aulos Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Aulos Bioscience worth (valuation)?
Valuation information for Aulos Bioscience is not publicly available.
Can I buy Aulos Bioscience stock?
Aulos Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aulos Bioscience's last funding round?
Aulos Bioscience's most recent funding round was Series A Extension on August 1, 2023.
Who are the main investors in Aulos Bioscience?
Key investors in Aulos Bioscience include Apple Tree Partners.
Will Aulos Bioscience IPO soon?
No public IPO plans have been announced for Aulos Bioscience.
How can I track Aulos Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aulos Bioscience's secondary market activity and sign up for updates.